Top Midday Gainers

MT Newswires Live

2024/08/06

Top Midday Gainers

TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.

TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.

Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.

Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.

Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.

Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.

Price: 32.95, Change: +20.64, Percent Change: +167.67

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2457709631"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2457709631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2457709631?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-06 01:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2457709631","market":"sh","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p>Top Midday Gainers</p><p> <a href=\"https://laohu8.com/S/TENKU\">TenX Keane Acquisition</a> (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.</p><p>TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.</p><p><a href=\"https://laohu8.com/S/ZVRA\">Zevra Therapeutics</a> (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.</p><p>Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.</p><p>Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.</p><p>Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.</p><p>Price: 32.95, Change: +20.64, Percent Change: +167.67</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-08-06 01:51</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>Top Midday Gainers</p><p> <a href=\"https://laohu8.com/S/TENKU\">TenX Keane Acquisition</a> (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.</p><p>TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.</p><p><a href=\"https://laohu8.com/S/ZVRA\">Zevra Therapeutics</a> (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.</p><p>Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.</p><p>Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.</p><p>Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.</p><p>Price: 32.95, Change: +20.64, Percent Change: +167.67</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4134","symbol_name":"信息科技諮詢與其它服務","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2457709631","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2457709631","pubTimestamp":1722880305,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Top Midday Gainers TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4134":"信息科技咨询与其它服务","BK4007":"制药","CTXR":"Citius Pharmaceuticals, Inc.","ZVRA":"Zevra Therapeutics","TWKS":"Thoughtworks Holding Inc."},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTXR":1,"ZVRA":1,"TENK":1,"TWKS":1},"content_text":"Top Midday Gainers TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.Price: 32.95, Change: +20.64, Percent Change: +167.67","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}